[unable to retrieve full-text content]
The FLOW-AF multicenter, randomized controlled trial shows Ablacon's Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation Yahoo Finance"flow" - Google News
February 04, 2023 at 06:00AM
https://ift.tt/e3UQyXx
The FLOW-AF multicenter, randomized controlled trial shows Ablacon's Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation - Yahoo Finance
"flow" - Google News
https://ift.tt/mJiZPGU
https://ift.tt/BOFu5NI
Bagikan Berita Ini
0 Response to "The FLOW-AF multicenter, randomized controlled trial shows Ablacon's Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation - Yahoo Finance"
Post a Comment